New drug tested for Hard-to-Treat thyroid condition
NCT ID NCT05907668
Summary
This study tested whether a drug called batoclimab could help control Graves' disease in adults whose thyroid hormone levels remained too high despite standard medication. Thirty-five participants received batoclimab injections for 24 weeks while researchers monitored their thyroid levels and safety. The goal was to see if this new treatment could help normalize thyroid function, potentially allowing patients to reduce or stop their other medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site Number - 6505
Mainz, 55131, Germany
Conditions
Explore the condition pages connected to this study.